Short answer
IDEAYA Biosciences, Inc. (IDYA) filed an 8-K current report with the SEC on June 10, 2026 reporting Item 8.01 (Other Events). $323.6 million net proceeds strengthen IDEAYA’s funding for operations and clinical development.
IDEAYA Biosciences, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- $323.6 million net proceeds strengthen IDEAYA’s funding for operations and clinical development
- Offering issued 7,222,225 common shares at $27.00, creating immediate equity dilution
- Pre-funded warrants cover 5,555,576 additional shares at a $0.0001 exercise price
- Underwriters exercised their option in full, adding 1,666,669 shares beyond the base offering
- 60-day lock-up for directors, executives and the company limits near-term insider selling pressure
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other IDEAYA Biosciences, Inc. 8-K filings
Get the next IDYA 8-K as it lands
Follow IDYA for push alerts, or ask the research agent what this filing means.